Sigma Healthcare Eyes Boots in $14bn UK Retail Deal, Targeting Major Expansion and Market Impact
Australia’s Chemist Warehouse empire could be heading for a much bigger stage. Sigma Healthcare’s talks over Boots would reshape its capital structure, kill off IPO plans and hand it a UK pharmacy network with real scale. For FMCG suppliers, this is not just a corporate headline. A deal of this size could change buying power, … Read more